Search

Three polysaccharide-protein complexes of longan pulp (LP1-3) were isolated in this work. Their physicochemical characteristics and immunomodulatory effects on splenocytes, natural killer (NK) cells and macrophages in vitro were investigated. The carbohydrate portions of LP1-3 were principally composed of glucose, arabinose and mannose. LP3 displayed the maximal moisture absorption, and the thermal stability of LP2 was obviously higher than that of LP1 and LP3. All of them showed the characteristic polysaccharide and protein bands in the Fourier Transform Infrared (FTIR) spectrum. For a certain dose, all the fractions could significantly stimulate splenocyte proliferation, macrophage phagocytosis against neutral red, and NK cell cytotoxicity against YAC-1 lymphoma cell (P < 0.05). The results demonstrated that the polysaccharide-protein complexes of longan pulp have medical potential as immunotherapeutic adjuvants due to their immunomodulatory activities.

The aim of this study was to investigate the combined effects of mulberry leaf and oat bran on type 2 diabetes. Co-treatment of diabetic mice with mulberry leaf and oat bran for 28 days led to lower glucose level and better glucose tolerance capacity than either mulberry leaf or oat bran treatment. It was found that this combination resulted in more significant inhibitory effects on alanine transaminase and aspartate transaminase activities. Meanwhile, the enhancement on insulin receptor and glucokinase expressions and down-regulation on pyruvate carboxylase, phosphoenolpyruvate carboxykinase, and pyruvate dehydrogenase complex kinase expressions were also observed. Additionally, the combination increased the gut microbiota diversity, and reshaped the gut microbiota structure. Based on the above data, it is more feasible to affirm that the combined supplementation of mulberry leaf and oat bran is a potential adjuvant on the treatment of diabetes mellitus.

The immunomodulatory function of longan pulp polysaccharide-protein complex (LP3) was investigated in immunosuppressed mice models. Compared with the model control, peroral administration of 100 mgkg−1d−1 LP3 could significantly increase/enhance antibody production against chicken red blood cell (CRBC), concanavalin A (ConA)-induced splenocyte proliferation, macrophage phagocytosis, NK cell cytotoxicity against YAC-1 lymphoma cell, and interferon-gamma (INF-γ) and interleukin-2 (IL-2) secretion in serum (P < 0.05). The immunomodulatory effects, except for those on splenocytes and macrophages (P > 0.05), were also observed in mice administered with 50 or 200 mgkg−1d−1 LP3 (P < 0.05). The beneficial effects of 50–200 mgkg−1d−1 LP3 were comparable to those of 50 mgkg−1d−1 ganoderan. The strong immunomodulatory activity of LP3 confirmed its good potential as an immunotherapeutic adjuvant.